Investigators from the SWOG Cancer Research Network have developed and validated a risk prediction model for identifying ...

Herbal brain boosters are on the rise, but does science back them up? Here's some truth behind nootropics and their alleged ...

Anyone with any experience as an investor knows that while penny stocks can produce strong returns, they’re also risky. You ...

US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects ...

Clinical research will offer insight for specific targeting of active pharmaceutical ingredients (API) that will further support Phase 1 Human ...

Researchers from Deakin University reveal how yoyo dieting disrupts gut health, leading to weight regain and obesity-related ...

Despite this, there is a paucity of research examining the impact of these ... multi-phase explanatory study (REB 2023-8964) ...

The latest study should be a comfort for caffeine drinkers, but isn't necessarily a sign to start a new habit.

Mahableshwarkar M.D., DLFAPA, Senior Vice President, Clinical Development ... decades of pharmaceutical industry experience in new drug development across all phases of research (pre-IND to ...

According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Increased funding and new public health policies for sickle cell research are needed to ease the burden on low-income nations ...